Carregant...

Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases

BACKGROUND. Circulating tumor DNA (ctDNA) is a promising technology for treatment selection, prognostication, and surveillance after definitive therapy. Its use in the perioperative setting for patients with metastatic disease has not been well studied. We characterize perioperative plasma ctDNA and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Surg Oncol
Autors principals: Baumgartner, Joel M., Riviere, Paul, Lanman, Richard B., Kelly, Kaitlyn J., Veerapong, Jula, Lowy, Andrew M., Kurzrock, Razelle
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470602/
https://ncbi.nlm.nih.gov/pubmed/32767050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-08331-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!